ID   MTKP 97-12
AC   CVCL_6504
SY   TKMp97-12
DR   CLO; CLO_0007898
DR   ATCC; CRL-8985
DR   CCRID; 4201PAT-CCTCC00012
DR   Wikidata; Q54907007
RX   Patent=US5141742;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8985.
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transfected with: HGNC; 7037; MELTF.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
RX   Patent=US5141742;
RA   Brown J.P., Estin C.D., Plowman G.D., Rose T.M., Hellstrom K.E.,
RA   Hellstrom I., Purchio A.F., Hu S.-L., Pennathur S.;
RT   "Vaccines against melanoma.";
RL   Patent number US5141742, 25-Aug-1992.
//